Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
信迪利单抗（抗PD-1抗体）联合高剂量甲氨蝶呤、替莫唑胺和利妥昔单抗（抗CD20抗体）治疗原发性中枢神经系统淋巴瘤：一项II期研究
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-01941-x
Zeng, Zhiyong; Yang, Apeng; Yang, Jingke; Zhang, Sheng; Xing, Zhen; Wang, Xingfu; Mei, Wenzhong; Jiang, Changzhen; Lin, Junfang; Wu, Xiyue; Xue, Yihui; Wu, Zanyi; Yu, Lianghong; Wang, Dengliang; Chen, Jianwu; Zheng, Shufa; Lin, Qiaoxian; Chen, Qingjiao; Dong, Jinfeng; Zheng, Xiaoqiang; Wang, Jizhen; Huang, Jinlong; Chen, Zhenying; Chen, Ping; Zheng, Meihong; Zhou, Xiaofang; He, Youwen; Lin, Yuanxiang; Chen, Junmin
